$2.70 -$0.01 (-0.4%)

09:45 AM EDT on 06/20/19

TherapeuticsMD, Inc. (NASDAQ:TXMD)

CAPS Rating: 2 out of 5

Current Price $2.70 Mkt Cap $624.8M
Open $2.78 P/E Ratio 0.00
Prev. Close $2.71 Div. (Yield) $0.00 (0.0%)
Daily Range $2.69 - $2.78 Volume 82,587
52-Wk Range $2.22 - $6.09 Avg. Daily Vol. 71

Caps

How do you think NASDAQ:TXMD will perform against the market?

Add Stock to CAPS Watchlist

All Players

25 Outperform
5 Underperform
 

All-Star Players

5 Outperform
5 Underperform
 

Wall Street

1 Outperform
1 Underperform
 

Top NASDAQ:TXMD Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Teacherman1 (32.75)
Submitted July 11, 2014

Was on my watch list at $3.50, but decided to go ahead and stick my toes in the water. In light, so will watch to see if I want to hold or add more.They are basically a women's healthcare company selling prescription and over the counter prenatal… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:TXMD VS S&P 500 (SPY)

Fools bullish on NASDAQ:TXMD are also bullish on:

Fools bearish on NASDAQ:TXMD are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about TXMD.

Recs

0
Member Avatar StockFrogger (72.73) Submitted: 3/24/2017 12:03:03 AM : Outperform Start Price: $6.62 NASDAQ:TXMD Score: -84.08

This drug company's commitment to women's health will continue to drive growth, goodwill and brand loyalty for it's branded prescription, generic and OTC drugs. TXMD is a Buy with tremendous upside to a $24 target price in 12 months.

Recs

0
Member Avatar Costco21 (34.32) Submitted: 12/7/2016 7:57:05 PM : Outperform Start Price: $6.56 NASDAQ:TXMD Score: -89.17

cheap pipeline

Recs

0
Member Avatar mfgd (82.66) Submitted: 9/22/2016 12:25:29 PM : Outperform Start Price: $6.20 NASDAQ:TXMD Score: -93.66

In company news (9-20), TherapeuticsMD ( TXMD) was lower this afternoon, giving back earlier gains Tuesday that followed the women's health care company late Monday saying federal regulators have accepted the new drug application for its Yuvvexy softgel treatment for painful sex in older women.

Acceptance of the application by the U.S. Food and Drug Administration starts the clock for the agency to make a final decision on market approval for the dyspareunia product candidate by May 7, 2017.
Better late than never. This is a long term pick.

Leaderboard

Find the members with the highest scoring picks in TXMD.

Score Leader

glenn12345

glenn12345 (99.98) Score: +155.06

The Score Leader is the player with the highest score across all their picks in TXMD.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
whatisthepoint 97.55 6/1/2016 Underperform 5Y $8.94 -69.63% +39.65% +109.28 0 Comment
GuruSLB 93.86 6/20/2017 Underperform 5Y $5.51 -50.73% +20.34% +71.06 0 Comment
WildShaman 93.50 7/5/2018 Underperform 5Y $6.35 -57.24% +7.72% +64.97 0 Comment
glenn12345 99.98 12/20/2018 Underperform 5Y $3.64 -25.41% +17.96% +43.38 0 Comment
Teacherman1 32.75 6/11/2019 Outperform 3Y $2.40 +13.12% +1.58% +11.54 0 Comment
tbailey82 < 20 11/12/2018 Outperform 5Y $4.91 -44.70% +5.77% -50.48 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. Under5 < 20 6/2/2017 Outperform 5Y $4.60 -40.98% +20.34% -61.32 0 Comment
Momentum21 81.47 10/4/2017 Outperform 5Y $5.25 -48.29% +15.91% -64.20 0 Comment
frak4318 97.16 6/22/2018 Outperform 5Y $7.11 -61.81% +6.36% -68.17 0 Comment
Bigsef77 68.69 6/22/2018 11/13/2018 Outperform 3Y $7.11 -61.81% +6.36% -68.17 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 86.25 12/1/2016 Underperform 3W $5.90 -53.98% +33.53% +87.51 0 Comment
TrackJimCramer 86.25 4/1/2015 Outperform 3W $6.37 -7.38% +6.74% -14.12 12/1/2016 @ $5.90 0 Comment
TrackFBRCapitalM 85.04 7/8/2014 Outperform NS $5.25 -48.29% +48.71% -97.00 0 Comment

Advertisement